The Recall Lawyers

Sales of the Infuse bone-growth protein made by Medtronic Inc. are in a nosedive after reports that the U.S. Senate is investigating safety problems with the product.
Medtronic sold $800 million worth of Infuse in its latest fiscal year, but Infuse sales are now declining sharply in the wake of news reports about safety issues.

A recent analysis, for example, showed that when the growth protein is used in spine surgery there is a possible higher rate of cancer. The types of cancer cited in the study include, breast cancer, pancreatic cancer, and prostate cancer. If you or a loved one has been injured by Infuse, contact the attorneys at Jones Ward PLC for a free consultation. Call Jasper Ward at 502-882-6000 or email jasper@jonesward.com.

The controversy over the Infuse bone-growth protein made by Medtronic continues, with California's attorney general issuing another subpoena to Medtronic forcing the company to cough up documents.
Medtronic, based in Minnesota, already is under fire for allegedly downplaying the safety risks associated with Infuse. According to news reports and scientific studies, the potential dangers of the drug include uncontrolled bone growth, a heightened risk of cancer, and male sterility. If you or a loved one has been injured by Infuse, contact the attorneys at Jones Ward PLC for a free consultation. Call Jasper Ward at 502-882-6000 or email jasper@jonesward.com.